T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results Read more about T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results
T2 Biosystems Announces Positive Results upon Completion of U.S. Clinical Evaluation for the T2Biothreat Panel Read more about T2 Biosystems Announces Positive Results upon Completion of U.S. Clinical Evaluation for the T2Biothreat Panel
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results Read more about T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results
T2 Biosystems Announces Third Quarter 2022 Financial Results Read more about T2 Biosystems Announces Third Quarter 2022 Financial Results
T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook Read more about T2 Biosystems Announces Preliminary Third Quarter 2022 Financial Results and Updates 2022 Financial Outlook
T2 Biosystems Announces Second Quarter 2022 Financial Results Read more about T2 Biosystems Announces Second Quarter 2022 Financial Results
T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results Read more about T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results
T2 Biosystems Announces First Quarter 2022 Financial Results Read more about T2 Biosystems Announces First Quarter 2022 Financial Results
T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results Read more about T2 Biosystems Announces Fourth Quarter & Full Year 2021 Financial Results
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results Read more about T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
